D.O'SheaD.GunnI.BeakS
Retatrutide 5 Mg Retatrutide (LY3437943) is an investigational peptide originally developed by Eli Lilly
Early phase 2 clinical trials have reported weight reductions of 2030% of body weight at higher mg doses, figures that, if validated in larger trials, would represent a clinically significant advance over current options
Novo Nordisk lists dose-dependent savings and self-pay pricing for the oral Wegovy pill, with terms and eligibility that should be verified directly with the manufacturer
But so have the forces pushing patients toward compounding in the first place: brand drugs priced out of reach, limited insurance coverage, and middlemen who distort access
Scenario 2: No insurance, paying cash for FDA-approved meds With Ro: Membership: $149/mo Wegovy pill: $149/mo (promotional) Zepbound vial: $299$449/mo Total: $298$598/month With Noom (Telehealth for Branded Meds): Membership: $99/mo Brand-name meds at pharmacy: $349+/mo Total: $448+/month Verdict: Ro wins lower total cost through manufacturer partnerships
